Share this page

 CORVAL — 2160345

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2160345

Registration number

TMA1322437

Type(s)

Standard Characters

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2022-01-14

Registered

2025-06-13

Registration Expiry Date

2035-06-13

Registered Owner

Corval LLC
26 White Oak Road
Waban, MA 02468
UNITED STATES OF AMERICA

Agent

MLT AIKINS LLP
2100 Livingston Place
222-3rd Avenue SW
Calgary
ALBERTA T2P0B4

Documents

View documents

Index headings

  • CORVAL

Services (Nice class & Statement)

35
(1) Consulting services in the fields of life sciences and biotechnology, namely, providing business planning and strategy services to manufacturers relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Consulting services in the fields of life sciences and biotechnology, namely, providing strategic roadmaps to manufacturers to inform business planning, identify objectives and track activities relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease
42
(2) Providing software as a service (SaaS), namely, non-downloadable web-based software for use by manufacturers in the fields of life sciences and pharmaceuticals for facilitating and streamlining the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Providing collaborative planning and technology solutions to manufacturers in the fields of life sciences and pharmaceuticals, namely, providing web-based software for cloud-based collaboration and strategic planning relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Development and implementation of collaborative planning and technology solutions for use by manufacturers in the fields of life sciences and pharmaceuticals, namely, development and implementation of web-based software that enables users to connect and collaborate with each other to plan business and market entry strategies relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease

Action History

Actions
Action Action date Due date Comments
Filed 2022-01-14
Created 2022-01-14
Formalized 2022-01-14
Pre-Assessment Letter Sent 2022-07-13 Goods or Services Not Acceptable
Search Recorded 2025-02-19
Approved 2025-02-27 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2025-02-27 APPROVED BY PROGRAM EX200M1
Advertised 2025-03-26 Vol.72 Issue 3674
Registration Pending 2025-06-13
Registered 2025-06-13 2035-06-13
Report a problem on this page
Date modified: